InMode Ltd. Stock News

Inmode Ltd shares slid more than 12% in pre-market trading on Wednesday after the medical tech company reduced its full-year 2023 guidance, due primarily to stronger-than-expected headwinds from the c

The stock of InMode Ltd. INMD, -4.33%, an Israeli medical tech company, fell 13% early Wednesday, after the company cut its full-year guidance to reflect stronger-than-expected headwinds from the curr

InMode (INMD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

InMode exhibited financial resilience in Q3 2023, with a modest increase in revenue and a significant rise in international sales. The stock price has recently declined but is now consolidating at low

InMode Ltd. investors experienced a collapse in October 2023 as INMD fell to a three-year low. I assessed that buyers have returned in November, potentially helping INMD to form a pivotal long-term bo

InMode, known for laser technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve drive demand, but geop

InMode (INMD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.

InMode (INMD) closed at $19.13 in the latest trading session, marking a -0.62% move from the prior day.

The business entered my High Quality and Bad Momentum Screener. War concerns have had limited impact on the company's sales and profitability, as most of its sales are from foreign markets. InMode rev

InMode (INMD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

DexCom is a big name in diabetes care, and investors may be overly bearish on the stock. InMode recently downgraded its guidance as rising interest rates impact its sales activity.

InMode (INMD) reachead $21.23 at the closing of the latest trading day, reflecting a -0.42% change compared to its last close.

Inmode Ltd shares sank 21% to $22.22 in late-morning trading on Thursday after the medical technologies provider announced that it now expects full year 2023 revenue to be in the range of $500 millio

After a miserable 2022, the stock market recovered in 2023 and surprised many investors. Artificial intelligence stocks grabbed the spotlight as investors dreamed of the possibilities.